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9. Health Priorities for Sustainable Development
Lisa E. Sachs and Jeffrey D. Sachs

Introduction1
The right to health has been repeatedly recognized as one of the core human rights. Good
health is so essential for human functioning, human dignity, economic well-being, and
development that the achievement of good health is among the highest goals of international and
national policies, and one of the highest commitments assumed by Member States within the
United Nations (UN) and its various bodies. Three of the eight Millennium Development Goals
(MDGs) adopted for 2000-2015 were focused on health (Goal 4 on child survival, Goal 5 on
maternal health, and Goal 6 on disease control). Sustainable Development Goal 3 (to “ensure
healthy lives and promote well-being for all at all ages”) for the period 2015-2030 is even more
expansive, not only including the three MDG goals but also calling for Universal Health
Coverage (SDG Target 3.8) among other objectives.2 Health is also deeply implicated in most of
the other 16 SDGs, especially those relating to poverty and hunger, inequalities, water and
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sanitation, decent work, human settlements, education, gender equality, environmental
sustainability, climate change, marine resources, terrestrial ecosystems, and global partnership.3
The COVID-19 pandemic has, of course, put public health and healthcare into the
forefront of policy and daily life as perhaps never before in modern times, and certainly to an
extent unprecedented since the Flu epidemic of 1918-19. The pandemic has not only been a
human tragedy and upheaval, but also another vivid proof of just how far we are from realizing
the universal right to health. Once again, we are seeing the disease burden fall
disproportionately on poor and vulnerable populations. Not only has the pandemic so far killed
well over 1 million people as of October 2020, with confirmed infections of more than 40
million, but it has devastated national economies, raised extreme poverty and hunger by
hundreds of millions of people, and set back the SDGs by many years.
By any reasonable standard, the right to health eludes hundreds of millions and with
COVID-19, perhaps billions of people. The most serious deficiencies are in poor countries, but
are also in middle-income and even rich countries, notably the United States, which has the
worst health coverage among the high-income countries. Even countries in Western Europe,
renowned for their health coverage and high life expectancy, have done a very poor job in
containing the COVID-19 pandemic.
There are several factors that account for the gross international disparities in health
outcomes. From an epidemiological point of view, the excess disease burdens in low-income
settings relate mainly to the high burden of disease associated with three main conditions:
infectious diseases (such as AIDS, TB, malaria and now COVID-19), nutritional deficiencies,
and maternal and perinatal conditions.4 In turn, the challenges of rampant infection, chronic
malnutrition, and unsafe childbirth relate to several underlying factors, including unsafe drinking
water leading to water-borne diseases, unsafe living conditions, chronic infections, and lack of
access to health facilities for prevention and treatment, to name a few. These conditions in turn
depend upon socioeconomic, political and environmental factors, including: the levels of income
of households, the community, and the nation; the policies and expenditures of government at all
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levels; the education, incomes, and behaviour patterns of individual households; the ecological
conditions that affect the transmission of diseases (such as worms and malaria) and access to safe
water; the vulnerability of the region to natural hazards, such as droughts, floods, and extreme
storms; the productivity of local agriculture; and the transport costs and trade policies regarding
foodstuffs and other critical inputs for health. The challenges and outcomes of the 17 Sustainable
Development Goals are therefore inherently inter-linked; achieving the goals related to health
requires policy interventions across many of the other goals and targets as well.5
COVID-19 has also made vivid the shortfalls in public health and healthcare in the rich
countries as well, most notably the United States, which has the most unequal access to health
care of any of the high-income countries in the OECD. Though the rich countries were
purportedly the most prepared of all countries in the world to deal with a public health
emergency, in practice, the rich countries of North America (Canada and the US) and many of
the countries of Europe performed very poorly in containing the pandemic during 2020. These
countries lacked effective systems of disease surveillance, testing, contact tracing, and
quarantining that are paramount in epidemic control, and the governments lacked the confidence
and backing of the general public needed to implement key behavioural changes.

The poverty-disease trap of low-income countries
Since 2000, economists have increasingly emphasized the centrality of health to
economic wellbeing, tracing the linkages from improved health outcomes to economic growth
and development, and also working with epidemiologists to identify the most effective ways to
invest in improved health. The Commission on Macroeconomics and Health of the World Health
Organization (2000-1) found that improved health powerfully raised living standards of the
population and promoted economic growth through several channels, including the accumulation
of human capital (education, skills, and physical health over the lifecycle) and a faster
demographic transition to lower fertility rates, resulting in greater increases in output per capita. 6
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Importantly, however, the reverse is also true: the main overarching risk factor for poor health is
poverty, a fact proved in a multitude of ways, including comparisons across societies and across
socioeconomic groups within societies. One compelling illustration of the impact of poverty on
health is the low life expectancy in the poorest countries. While high-income countries have a
life expectancy at birth of nearly 80 years, least-developed countries have a global average of 60
years.7 Similar discrepancies exist on other broad measures, such as infant mortality and
mortality of children under age 5.
Many policy makers have now appropriately recognized the poverty-disease nexus as a
“poverty trap:” economic development and ample financial resources are required to alleviate the
poverty-related burdens of poor health, low literacy, and resource depletion, yet economic
development is blocked by precisely these poverty-related burdens, which decrease productivity,
earning ability, and economic investments. Poor communities lack both basic infrastructure and
the means to ensure access to health interventions, and remain poor as a result. Poor nations are
unable to fund health systems at all levels. They are also generally more vulnerable to diseases
in part because of the disproportionate geographic burden of infectious diseases in tropical
countries. Yet unhealthy people, in turn, are burdened by low economic productivity – due to
chronic physical ailments, absenteeism, under-schooling (e.g., disease-related dropouts) and
long-term cognitive and physical disabilities – which prevent them from generating the income
and public tax revenues required to tackle the underlying causes of poor health.
The implications of a poverty-disease trap (and of a poverty-human capital trap more
generally) are profound. They suggest that poor countries on their own are unable to realize the
human rights to health and education, the constituents of human capital vital for skill
development and active labor force participation and labor productivity. Improved health and
education require increased public outlays and infrastructure that are beyond the financial means
of the poor countries themselves. Yet without improved health and education, economic progress
itself is put in jeopardy. The only way to break the vicious circle of poverty and low human
capital (health and education) may be to intervene from the outside, for example, through
development aid that is directed at improving the health and educational attainment of the low-
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income population. Of course, international development aid is probably best directed not only at
ameliorating poor health and education but at ending all aspects of the poverty trap, including:
low human capital, poor infrastructure, poor governance, and environmental vulnerability.
Building on the work of the Commission on Macroeconomics and Health in 2000-1, the
World Health Organization (WHO) has continued to put a price tag on international investment
in health systems. The WHO Health Financing Working Paper No. 1 found that a rudimentary
healthcare system in a low-income country would require US$86 per capita as of 2015 (in 2012
US dollar terns).8 Another report from WHO found that the bottom 10 countries in terms of per
capita health spending were able to muster only around US$30 per person per year, requiring
international assistance to make up the difference.9
More recently, the IMF has studied the financing gap facing 57 Low-Income Developing
Countries (LIDC) in achieving the SDGs.10 The IMF’s careful methodology was the following.
For five of the key SDG categories – health, education, roads, electricity, and water and
sanitation – the IMF estimated the public-sector outlays required to achieve the 2030 SDG
targets, and then considered the potential domestic budget revenues available to fund these
outlays. The Fund recognized that the LIDCs would have to increase their domestic resource
mobilization through higher tax collections, but that there would be practical and economic
limits in doing so. As a result, the Fund determined that there is an intrinsic SDG financing gap
between what the countries need to spend on SDG objectives and what they can fund
domestically out of public revenues. The gap, notes the Fund, will have to be filled through
international development assistance or some related means (such as global tax reforms that
increase the ability to raise domestic revenues).
According to the IMF’s calculations, meeting the SDGs requires an increase in outlays of
around $528 billion as of 2030 (in $US 2016 prices), but increased domestic revenues can cover
only around $170 billion per year, leaving an SDG financing gap of around $358 billion.
Notably, this amounts to only around 0.3 percent of GDP, or around 0.7 percent of the GDP of
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the donor countries. While the IMF did not allocate the gap across sectors, we can estimate that
of the $358 billion annual gap, health coverage may account for around $50 billion per year, on
the order of 0.1 percent of the GDP of the high-income OECD countries. Note of course that
these estimates did not anticipate the added costs of fighting the COVID-19 pandemic (both the
direct health costs and also the more general economic costs and losses to government budgets).
Although this chapter heavily focuses on the international disparities, and the yawning
gaps in health achievement in the lower-income countries, the Coronavirus pandemic has
underscored how poverty also impinges on health at the household and local community level.
The Coronavirus has disproportionately impacted disadvantaged and marginalized populations
within high-income countries, both in terms of infection rates and outcomes. Groups particularly
affected include the elderly, particularly those in residential care facilities, and populations with
pre-existing health risks exacerbated by poverty, poor nutrition, and disproportionately poor
health services. Workers in the service industry, which are predominantly lower-paying jobs with
fewer benefits including healthcare benefits, protective equipment, paid sick leave, and job
protections, remain most vulnerable to both transmission and poorer outcomes.11 The
international right to health discussed throughout this Chapter applies as vigorously to the poorer
and vulnerable populations within high-income countries as well, with corresponding
implications for necessary policies, investments and financing.

The SDG Context (SDG 3)
For the period 2016-2030, the globally agreed targets for health are contained in SDG 3, which
calls on all countries to “ensure healthy lives and promote wellbeing for all at all ages.” The
specific targets are described in Box 1. These are enormously ambitious goals, as they call for
all countries to achieve minimum acceptable standards on maternal mortality, newborn mortality,
and under-5 mortality, as well as the end of the AIDS, TB, malaria, and neglected tropical
disease epidemics, dramatic reductions of non-communicable diseases, and universal access to
healthcare, among other targets. While these objectives are technically within reach, they would
require a significant scale-up of public investments in most developing countries, and a
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significant annual transfer of funds from the high-income donor nations to the low-income
developing countries to finance the increased outlays, on the order of $50 billion per year.

Box 1. SDG 3 Targets

3.1 By 2030, reduce the global maternal mortality ratio to less than 70 per 100 000 live births.
3.2 By 2030, end preventable deaths of newborns and children under 5 years of age, with all
countries aiming to reduce neonatal mortality to at least as low as 12 per 1000 live births and
under-5 mortality to at least as low as 25 per 1000 live births.
3.3 By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases
and combat hepatitis, water-borne diseases and other communicable diseases.
3.4 By 2030, reduce by one third premature mortality from non-communicable diseases through
prevention and treatment and promote mental health and well-being.
3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse
and harmful use of alcohol.
3.6 By 2020, halve the number of global deaths and injuries from road traffic accidents.
3.7 By 2030, ensure universal access to sexual and reproductive health-care services, including
for family planning, information and education, and the integration of reproductive health into
national strategies and programmes.
3.8 Achieve universal health coverage, including financial risk protection, access to quality
essential health-care services and access to safe, effective, quality and affordable essential
medicines and vaccines for all.
3.9 By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals
and air, water and soil pollution and contamination.
3.a Strengthen the implementation of the WHO Framework Convention on Tobacco Control in
all countries, as appropriate.
3.b Support the research and development of vaccines and medicines for the communicable and
non-communicable diseases that primarily affect developing countries, provide access to
affordable essential medicines and vaccines, in accordance with the Doha Declaration on the
TRIPS Agreement and Public Health, which affirms the right of developing countries to use to
the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights
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regarding flexibilities to protect public health, and, in particular, provide access to medicines for
all.
3.c Substantially increase health financing and the recruitment, development, training and
retention of the health workforce in developing countries, especially in least developed countries
and small island developing States.
3.d Strengthen the capacity of all countries, in particular developing countries, for early warning,
risk reduction and management of national and global health risks.

Global cooperation to realize the human right to health
The two-way nexus between poverty and health has been widely recognized by United
Nations bodies, other intergovernmental organizations, governments, and academics, which have
placed a price tag on the needed assistance. Yet despite this broad understanding of the vicious
cycle of poverty and disease - and international capacity to break that cycle - the international
community has mustered only a laggard and insufficient response to the poverty-disease trap. We
thus find ourselves in a dangerous and unjustifiable predicament: the countries that bear the
disproportionate burden of disease have the least capacity to do anything about it, yet the
countries with sufficient means have been derelict in making available the necessary resources to
improve health outside their own countries.12 Ironically, in addition to neglecting their
commitments to alleviate poverty and disease in low-income countries, rich countries are also
putting themselves at risk; as the Coronavirus, like several other viruses in recent years, has
shown us, many infectious diseases do not respect country borders and can easily spread from
continent to continent. For this reason, one scholar wisely and presciently noted that
“safeguarding the world's population requires cooperation and global governance.”13
Despite earlier steps to promote global cooperation on issues of health and poverty, like
the Global Fund to Fight AIDS, TB, and Malaria of the Global Alliance for Vaccines and
Immunizations launched in 2002, official development assistance (ODA) for health as a
percentage of total ODA has failed to increase over the last decade—13.1% in 2009 and
13.0% in 2018—while total volume of health ODA has increased only modestly during

Lawrence O. Gostin, “A Proposal for a Framework Convention on Global Health,” Journal of International
Economic Law 10(4) (2007): 989-1008.
13
Ibid., 989.
12
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the past decade—peaking at $24.4 billion in 2017 before falling to $22.2 billion the
following year.14 This annual flow is perhaps $30 billion per year less than needed to achieve
the SDGs in a typical year, with an even greater gap when we add the costs of COVID-19
control. Realizing the right to health therefore requires a system of increased financial transfers
and proper management systems to ensure that international resources reliably and accountably
reach those in need. Human rights, economic development, and public management merge at this
point, requiring a new and effective form of cooperation among human rights advocates, public
health specialists, public health economists, and public-sector managers.

The right to health under international law
In addition to the economic imperative to invest in the right to health (and the moral
imperative to prevent unnecessary disease and deaths), there is also a legal imperative grounded
in binding international legal instruments, wherein States have undertaken to realize specific
human rights, including through “international assistance and cooperation.”15 The universal right
to health was one of the fundamental human rights envisioned by the nascent intergovernmental
organizations in the mid-twentieth century and has been embodied in numerous
intergovernmental treaties, declarations and resolutions.16 Indeed, every country in the world is
party to at least one international convention or treaty that includes the affirmation of health
rights and imposes obligations relevant to achieving the right to heath.17
At the formation of the UN in 1945, one of the first intergovernmental organizations
envisioned to supplement the mandate and authority of the UN was a global health

Duncan Knox, “Aid spent on health: ODA data on donors, sectors, recipients,” Development Initiatives, July
2020, https://devinit.org/resources/aid-spent-health-oda-data-donors-sectors-recipients/#section-1-2.
15
UN General Assembly, International Covenant on Economic, Social and Cultural Rights (ICESCR), UN General
Assembly Resolution 2200A (XXI), 16 December 1966,
https://www.ohchr.org/en/professionalinterest/pages/cescr.aspx, Article 2(1); UN Charter arts. 1(3), 55, 56; UDHR
art. 22; Convention on the Rights of the Child, opened for signature Nov. 20, 1989, arts. 4, 24(4), 144 U.N.T.S. 123,
(entered into force Sept. 2, 1990). See also Octovio Ferraz and Judith Bueno de Mesquita, “The Right to Health and
the Millennium Development Goals in Developing Countries: A right to International Assistance and Cooperation?”
Right to Health Unit, Human Rights Centre, University of Essex, July 2006,
http://repository.essex.ac.uk/9786/1/right-to-health-millenium-development-goals-developing-countries.pdf.
16
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Lawrence O. Gostin (eds.), Advancing the Human Right to Health, Oxford University Press, 2013, pp. 3-23
17
P.C. Kuszler, “Global Health and the Human Rights Imperative,” Asian Journal of WTO & International Health
Law and Policy, vol. 2, 2007, 99.
14
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organization.18 Less than three years after the UN Charter came into force, the WHO was
formed, and its constitution came into force on April 7, 1948.19 According to the WHO
constitution, “the enjoyment of the highest attainable standard of health is one of the
fundamental rights of every human being without distinction of race, religion, political belief,
economic or social condition,”20 and the mission of the WHO is “the attainment by all peoples of
the highest possible level of health.”21 The WHO has the power to adopt conventions (Article
19), promulgate binding regulations (Article 21), make recommendations (Article 23), and
monitor the national health legislation (Article 63) of its Member States.
The first two of these powers are quite important. The WHO, by a two-thirds vote, can
adopt binding conventions or regulations, which Member States are affirmatively required to
submit to their national legislative bodies for ratification, and to notify the Director-General of
the action the State has taken within eighteen months. If the national legislature does not ratify
an adopted convention, the State must report its reasons to the Director-General (Article 20).
Similarly, all adopted regulations are binding on Member States unless the State specifically
rejects the regulation (Article 22). In general, all members of the WHO have an obligation to
adopt measures and legislation that are consistent with the stated goals and declarations of the
WHO and not to adopt any measures that directly contravene any of these goals. Despite its
extraordinary legislative powers, the WHO has been reluctant to create binding norms that could
help achieve international cooperation on the universal right to health. The WHO has only
adopted four binding legal instruments: the 1967 Nomenclature Regulations, two instruments
related to tobacco production—one in 2003 and one in 2013—and the International Health
Regulations (IHR). The IHR date back to 1951, but as of 1995, the treaty only applied to cholera,
the plague, and yellow fever.22 While calls for reform emerged in the mid-1990s, the SARS
epidemic in China in the early 2000s catalyzed the major overhaul of the International Health
Regulations in 2005.23

World Health Organization, “Global Health Histories: Origin and development of health cooperation,”
https://www.who.int/global_health_histories/background/en/.
19
Ibid.
20
Constitution of the World Health Organization, opened for signature 22 July 1946, 62 Stat. 6279, 14 UNTS 185,
preamble.
21
Ibid.
22
Ibid.
23
Ibid., 267.
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The International Health Regulations (IHR) of 2005, which came into force in 2007,
legally bind 196 States Parties to certain rights and obligations “to prevent, protect against,
control and provide a public health response to the international spread of disease.”24 While
previous versions of the IHR were disease-specific in nature, the scope of the 2005 IHR included
health issues related to biological, chemical, and radionuclear events.25 The IHR obligate States
Parties to collaborate with one another to develop and maintain core capacities and infrastructure
to detect, prevent, contain and report threats to health before they cross international borders.26
The IHR also include the Director-General’s exclusive power to declare and to terminate a public
health emergency of international concern (PHEIC) and to provide temporary, non-binding
recommendations for States Parties to take in light of the emergency situation.27 The DirectorGeneral declared a PHEIC in 2009 for the H1N1 influenza pandemic, which was met with
criticism and laxity from States. After this pandemic, in 2011, the WHO Review Committee
responsible for evaluating the IHR implementation and WHO response to the H1N1 pandemic
warned that “[t]he world is ill-prepared to respond to a severe influenza pandemic or to any
similarly global, sustained and threatening public-health emergency.”28 In 2014, the Director
General declared two different PHEICs, for Ebola and polio, and then in 2016 the Director
General declared the fourth ever PHEIC for the Zika pandemic.29 On January 30, 2020, the
Director-General of the WHO convened the IHR Emergency Committee, declared the COVID19 outbreak a PHEIC and issued corresponding temporary recommendations.30
The Universal Declaration of Human Rights (UDHR), adopted in 1948, reaffirms the
right to health in the context of the right to an adequate standard of living (Article 25 (1)). The
UDHR is not a treaty and therefore is not legally binding on the Member States of the UN, but
“unlike many subsequent declarations, the UDHR “enjoys a more elevated status, largely
World Health Organization, “States Parties to the International Health Regulations (2005),”
https://www.who.int/ihr/legal_issues/states_parties/en/; WHO, International Health Regulations, art 2. (2005),
https://www.who.int/publications/i/item/9789241580496.
25
Lawrence O. Gostin, Mary C DeBartolo, and Erin A. Friedman, “The International Health Regulations 10 years
on: the governing framework for global health security,” The Lancet 386 (2015): 2222-26, 2222.
26
Ibid.
27
Lawrence O. Gostin and Rebecca Katz, “The International Health Regulations: The Governing Framework for
Global Health Security” (2016). Georgetown Law Faculty Publications and Other Works. 1770.
https://scholarship.law.georgetown.edu/facpub/1770, 273.
28
Ibid.
29
Ibid., 273–74.
30
World Health Organization, “Timeline of WHO’s response to COVID-19”, https://www.who.int/news/item/2906-2020-covidtimeline.
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because of its foundational role and universal acceptance,”31 and it can be used “as an
interpretative instrument and can give rise to customary law.”32 Unlike the UDHR, the
International Covenant on Economic, Social and Cultural Rights (ICESCR) is legally binding on
States that sign and ratify it, although States are then allowed to demur from specific articles of
the Covenant through reservations, by restricting their obligations under the treaty. The core
provision on the international right to health is Article 12 of the ICESCR, which recognizes “the
right of everyone to the enjoyment of the highest attainable standard of physical and mental
health. [Steps required] include those necessary for…the prevention, treatment and control of
epidemic, endemic, occupational and other diseases [and]…the creation of conditions which
would assure to all medical service and medical attention in the event of sickness.”33
The formal content and scope of the right to health has been further clarified through a
series of UN documents, especially General Comments issued by the Committee on Economic,
Social and Cultural Rights (CESCR). The CESCR is responsible for the promotion,
interpretation and implementation of the ICESCR, and from time to time issues General
Comments that attempt to clarify the scope of the rights and obligations of the State Parties with
respect to the various articles and provisions of the ICESCR. These General Comments are not
binding on the parties, but they nevertheless are “recognised as having significant legal weight
and offering jurisprudential insights into the rights enumerated in the ICESCR.”34
In May 2000, the CESCR adopted General Comment No. 14 on the “Right to the Highest
Attainable Standard of Health.”35 The Comment specified that while the right to health certainly
includes the right to equal and timely access to health services, it also requires States Parties to
ensure the underlying determinants of health, including safe drinking water, essential medicines,
essential food, basic shelter, and sanitation. Furthermore, the Comment recognized that universal
Kuszler, “Global Health and the Human Rights Imperative,” supra, note 17.
Ferraz and Mesquita, “The Right to Health and the Millennium Development Goals,” supra, note 15.
33
ICESCR, supra, note 15, Article 12. Several non-binding WHO and UN General Assembly resolutions and
international agreements have reaffirmed the international commitment to the right to health. For instance, the
Alma-Ata Declaration, adopted in 1978 at the International Conference on Primary Health Care in Alma-Ata,
Kazakhstan, convened by the WHO and the United Nations Children's Fund (UNICEF) reaffirmed that health is a
“fundamental human right” and called for all countries to “cooperate in a spirit of partnership and service to ensure
primary health care for all people since the attainment of health by people in any one country directly concerns and
benefits every other country.” WHO, Declaration of Alma-Ata, Alma·Ata, International Conference on Primary
Health Care, USSR, 6-12 September, 1978, https://www.who.int/publications/almaata_declaration_en.pdf
34
Ferraz and Mesquita, “The Right to Health and the Millennium Development Goals,” 9, supra, note 15.
35
Committee on Economic, Social and Cultural Rights, General Comment No. 14: The Right to the Highest
Attainable Standard of Health (Art. 12), UN Doc. E/C.12/2000/4, adopted 11 August 2000.
31
32
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access to essential medicines is a core, non-derogable duty of all Member States, as is
preventing, treating, and controlling epidemic and endemic diseases.36
Article 15(1)(b) of the ICESCR also states that everyone has the right “to enjoy the
benefits of scientific progress and its applications.”37 This right is significant in light of the
disproportionate disease burden in developing countries, the immense disparities in access to
essential medicines across the globe, and the inequitable number of medicines designed for
developing-country health needs. In 2001, the CESCR adopted a General Statement on “Human
Rights and Intellectual Property” that makes clear that the right to enjoy the benefits of scientific
progress—including medication—must be respected in the realm of international trade; and any
intellectual property regime must include provisions for protecting public health.38 Four years
later, the Committee consolidated its position on intellectual property and human rights in its
General Comment No. 17 wherein it stated that States have a duty to balance these interests in a
way that prevents unreasonably high costs for medication.39 In April 2020, the committee
reiterated the obligation of states to adapt intellectual property regimes “to allow universal access
to the benefits of scientific advances relating to COVID-19 such as diagnostics, medicines and
vaccines.”40
As a result, in large part, of the work of the Special Rapporteur in the field of cultural
rights,41 the CESCR adopted a General Comment in 2020 on the right to science, which the
Committee defines as “not only a right to receive the benefits of the applications of scientific
progress, but also a right to participate in scientific progress.”42 This General Comment No. 25
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addresses health in several important ways. It defines as one of the core obligations of this right
that States Parties “[e]nsure that in the allocation of public resources, priority is given to research
in areas where there is the greatest need for scientific progress in health, food and other basic
needs.”43 It also addresses, as it did in General Comment No. 17,44 the need to balance incentives
for the development of new products with access to health in light of the inaccessibility of
products and technologies when priced out of reach for low-income persons or developing
countries.45 The critical need for new discoveries to prevent and treat COVID-19 makes the
recommendations of the Committee all the more urgent, such as calling on States “to counter
distortions of funding associated with intellectual property, [by providing] adequate financial
support for research … either through national efforts or, if necessary, by resorting to
international and technical cooperation.”46

Responsibilities of donor nations to support health in low-income countries
Despite the universal recognition of the right to health as a basic human right,
international law is ill-equipped to protect and promote this right adequately, especially in the
developing world where the need is greatest. Traditional international human rights law is
premised on States having the primary obligation to protect and promote the human rights of the
citizens within their jurisdiction; thus, governments have the obligation to realize the right to
health of their own citizens. In low income countries, where governments do not have the
resources to achieve the universal right to health as envisioned in United Nations agreements, the
right to health should be “progressively” achieved, according to available resources. This means
that citizens of developing countries have different “highest attainable standards” of health than
do citizens of rich countries:47
Each State Party to the present Covenant undertakes to take steps, individually and
through international assistance and cooperation, especially economic and technical, to
the maximum of its available resources, with a view to achieving progressively the full
43
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realization of the rights recognized in the present Covenant by appropriate means,
including particularly the adoption of legislative measures.48
As noted in other chapters in this publication, the italicized words reflect the
acknowledgement in a legal instrument of the pragmatic approach favoured by economists based
on the fundamental reality of scarcity of resources. This approach overlooks two critical points
from an economic perspective. First, as already discussed, poor countries are marred in health
crises precisely because they do not have the resources to improve all aspects of a health system,
including clean drinking water, trained medical personnel, essential medicines and equipment,
health education, and other basic health fundamentals. Moreover, a healthy population is a key
component of economic development. When countries are caught in an extreme poverty trap, it
is illogical and impractical to insist that poor populations await the “progressive realization” of
their right to health, subject to the available resources of their government. Furthermore, the
focus on the right to health obligations of poor countries to their own populations overlooks the
legally binding obligations of third-party States to assist with the realization of the right to health
in resource-poor countries. The latter point is the focus of this section.
Again, from an economic perspective, prior to the COVID-19 pandemic, a transfer of just
0.1 per cent of rich States’ annual income would close the financing gap for realizing the right to
health in poor countries. It is a question of helping poor countries to reduce their resource
constraints to allow them to meet the health needs of their populations. But importantly, the
economics of financial transfers to realize the right to health is again backed by international law.
The overarching obligation of all UN Member States to cooperate for the achievement of human
rights is articulated in the UN Charter. Specifically, the Charter states that the purposes of the
UN are to “achieve international co-operation in solving international problems of an economic,
social, cultural or humanitarian character.”49 Articles 55 and 56 call for UN Member States to
take “joint and separate action in co-operation with the Organisation” to achieve the purposes of
the UN, which include “higher standards of living, full employment, and conditions of economic
and social progress and development.”50
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In 1990 the ICESCR referred to international assistance and cooperation in General
Comment 3, stating in particular that:
in accordance with Articles 55 and 56 of the Charter of the United Nations, with wellestablished principles of international law, and with the provisions of the Covenant itself,
international cooperation for development and thus for the realization of economic, social
and cultural rights is an obligation of all States. It is particularly incumbent upon those
States which are in a position to assist others in this regard.51

This obligation to assist in achieving the right to health for persons not within the
jurisdiction of a given State Party is further reinforced by the obligation, contained in the Vienna
Convention on the Law of Treaties, of States that are signatories but not parties to a treaty such
as the ICESCR “to refrain from acts that would contravene the object and purpose” of the treaty
until or unless the State makes it clear that it does not intend to become a party to the treaty.52
Moreover, States that are neither parties nor signatories to the ICESCR, including the United
States, still assume “general obligations not to contravene UN resolutions in this regard, as
members of the United Nations.”53
Several UN resolutions and declarations have affirmed the Member States' commitment
to international assistance, including in relation to access to medicines. The Millennium
Declaration, adopted by the General Assembly in 2000, recognized “a collective responsibility to
uphold the principles of human dignity, equality and equity at the global level.”54 Developed
countries agreed to undertake concrete actions such as the adoption of fair trade rules, debt relief
programmes for heavily indebted poor countries, and increased development assistance to poor
countries committed to poverty reduction. Several of the targets of SDG3 (“Ensure healthy lives
and promote well-being for all at all ages”), commit states to such assistance with respect to the
right to health, including to “[s]upport the research and development of vaccines and medicines
for the communicable and non-communicable diseases that primarily affect developing
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countries, provide access to affordable essential medicines and vaccine …and, in particular,
provide access to medicines for all” (3.b); to “[s]ubstantially increase health financing and the
recruitment, development, training and retention of the health workforce in developing countries,
especially in least developed countries and small island developing States” (3.c); and to
“[s]trengthen the capacity of all countries, in particular developing countries, for early warning,
risk reduction and management of national and global health risks.” (3.d)55 While these SDGs
are important guiding principles on the right to health, the UN Special Rapporteur on the Right
to Health recognized that “weak accountability requirements, unclear guidance on how to
implement the Sustainable Development Goals holistically and a failure to make commitments or
offer guidance on how to transform the global financial system to support such a broad and
ambitions global strategy” undermine their effective implementation.56
Indeed, the commitments States made by adopting the SDGs echo their legally binding
obligation to assist and cooperate with the realization of the right to health in impoverished
countries based on the language of the UN Charter and the specific language of the ICESCR,
including the interpretive comments of the CESCR. However, the lack of specific measures that
States should take to fulfil their legal obligations under the ICESCR and political commitments
under the SDGs have rendered these obligations unenforceable. The General Comments have
taken some steps to articulate the meaning of third-party State obligations. According to the
Comments, the CESCR envisions that third-party States have the same tripartite responsibilities
as those of States Parties to their own citizens: to respect, to protect and to fulfil all economic
and social rights referred to in the ICESCR. The third-party State obligation to respect human
rights in other countries and “to refrain from interfering with the realization of economic, social
and cultural rights in other countries” is the least contentious aspect of the third-party State
obligations and is generally understood to be the “minimum obligation.”57 For instance, General
Comment No.14 on the Right to Health states that all State Parties must “respect the enjoyment
of the right to health in other countries.”58
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However, the General Comments clearly indicate that the ICESCR envisions the
obligations of third-party States as going beyond the minimum of “respecting” rights in other
countries. General Comment No. 14 states that States Parties must also “prevent third parties
from violating the right [to health] in other countries, if they are able to influence these third
parties by way of legal or political means, in accordance with the Charter of the United Nations
and applicable international law.”59 The third-party State obligation to protect the realization of
human rights in all countries from the interference of third parties under its control has not yet
been conceptualized or enforced in practice, yet much has been written about the importance of
this obligation to “protect.” For instance, with respect to access to medicines, many have argued
that States Party to the ICESCR have a binding obligation to regulate the activity of
pharmaceutical companies that are incorporated within their State; accordingly, States would
violate the right to health under the ICESCR “by failing to influence pharmaceutical
corporations' actions that restrict access to HIV/AIDS drugs in developing countries.”60
In a report on the international health worker skills drain, the former Special Rapporteur
on the right to health, Paul Hunt, stated that, in accordance with the obligation to protect the right
to health in third countries, “developed countries should ensure that their human resource
policies do not jeopardize the right to health in developing countries.”61 He offered the following
example:
If a developed country actively recruits health professionals from a developing country
that is suffering from a shortage of health professionals in such a manner that the
recruitment reduces the developing country’s capacity to fulfill the right to health
obligations that it owes its citizens, the developed country is prima facie in breach of its
human rights responsibility of international assistance and cooperation in the context of
the right to health.62
Hunt carried the concept of the obligation to protect further by drafting and submitting to
the General Assembly a set of “Human Rights Guidelines for Pharmaceutical Companies in
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Relation to Access to Medicines.”63 The obligation to protect also requires third-party States that
are concluding international or regional agreements on any issue to ensure that these
instruments—such as bilateral or multilateral trade and investment agreements—do not
adversely impact the realization of the right to health in other countries; and states that are
members of international organizations, such as the World Bank, the WTO, and the IMF, are
obligated to influence the lending policies, credit agreements, and other international policies of
these institutions so that they are consistent with the objectives of the ICESCR.64
The final obligation – that to fulfil – is the most difficult of all the obligations to
conceptualize and to make operational. As one scholar noted, “any suggestion of a legal
obligation to provide development aid [...] has invariably been met by hesitation or rejection
from even the most generous donor countries.”65 Nevertheless, the General Comments clearly
envision aid – both financial and technical – to be an obligation of countries with available
resources for the realization of rights in poor countries. General Comment No.14 states that
“[d]epending on the availability of resources, States should facilitate access to essential health
facilities, goods and services in other countries, wherever possible and provide the necessary aid
when required.”66 In addition to General Comment No. 14, other General Comments to the
ICESCR have enumerated specific obligations of third-party States to assist with the realization
of rights in developing countries, including the right to adequate housing,67 the right to
education,68 the right to food,69 and the right to water.70 As the same scholar noted, despite the
existence of these third-party extraterritorial obligations to assist with the realization of human
rights in other countries, the obligations “to protect” and “to fulfil” are “still part of the law
‘under construction,’ that is the law as it ought to be.”71
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The emphasis here on the obligations of developed countries is not intended to minimize
the role that governments of poor countries have in the realization of the right to health and other
basic human rights in their own countries. Third-party extraterritorial obligations are
complementary to domestic State obligations.72 Poor governance, discrimination, corruption, and
warped ideology are unfortunate realities and impediments to the right to health in many
countries, developing and developed alike. Efforts to improve governance, accountability,
equitable distribution and access systems, and social justice are necessary but not sufficient to
achieving the universal right to health. The point stressed here is that poverty remains the most
critical obstacle to the realization of the right to health in developing countries and has only
increased as a result of COVID-19. Indeed, in its statement on COVID-19, the Committee on
Economic, Social and Culture Rights noted that health-care programs “have been weakened by
decades of underinvestment in public health services and other social programmes, accelerated
by the global financial crisis of 2007–2008. Consequently, they are ill equipped to respond
effectively and expeditiously to the intensity of the current pandemic.”73 The Statement
continues that the global crisis “highlights the crucial importance of international assistance and
cooperation,” noting that the “needs of vulnerable and disadvantaged groups as well as fragile
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countries, including least developed countries, countries in conflict and post-conflict situations,
should be at the centre of such international endeavours.”74
The WHO, in conjunction with other international organizations, has pushed for equitable
access to medicines and vaccines to combat the COVID-19 pandemic, but states’ participation in
such measures is not required, and some notable wealthy states such as the United States have
refused to participate. In April 2020, the WHO, World Bank, Gavi, and several private sector
partners, created the Access to COVID-19 Accelerator, which fosters collaboration between
governments, scientists, businesses, civil society, global health organizations, and private
philanthropists to accelerate the development and production of COVID-19 tests, treatments, and
vaccines and promotes equitable access to these resources.75 In the same month, the UN General
Assembly passed a resolution on international cooperation to ensure global access to medicines,
vaccines and medical equipment to face COVID-19.76
In May 2020, numerous world leaders, diplomats, economists, and academics called upon
the WHO to ensure that human rights are prioritized over corporate profit interest with respect to
a COVID-19 vaccine.77 They called for an agreement to be implemented by the WHO that
“[e]nsures mandatory worldwide sharing of all COVID-19 related knowledge, data and
technologies”; “[e]stablishes a global and equitable rapid manufacturing and distribution plan –
that is fully-funded by rich nations – for the vaccine and all COVID-19 products and
technologies that guarantees transparent ‘at true cost-prices’ and supplies according to need”;
and “[g]uarantees COVID-19 vaccines, diagnostics, tests and treatments are provided free of
charge to everyone, everywhere. Access needs to be prioritized first for front-line workers, the
most vulnerable people, and for poor countries with the least capacity to save lives.”

Achieving the right to health within the human rights framework
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The important question, therefore, is how to make operational the existing legal
obligations of developed countries to assist impoverished countries with the realization of the
right to health, and importantly, how to coordinate the efforts of domestic governments, donor
governments, and non-State actors in the realization of the right to health. As one commentator
has noted, “The most glaring problem, widely debated by scholars, is whether international legal
instruments and global institutions can effectively govern the diverse State and non-State actors
that influence health outcomes.”78 While this remains an incredibly complex – yet particularly
urgent – problem in this era of the COVID-19 pandemic, below we outline some of possible
steps that the international community can take to help achieve the right to health globally, which
is instrumental to the poverty reduction agenda.
As with most other economic, social and cultural rights in the ICESCR and the UDHR,
the right to health is not well defined in the human rights framework and the specific obligations
of governments and other actors have not been enumerated. In General Comment No. 14, the
CESCR identified several core obligations of the right to health, including the obligation of
developed countries to provide economic and technical assistance to developing countries.79
However, benchmarks and evaluation criteria are instrumental to encourage all governments to
meet their obligations and to assess which countries need assistance and in which areas.
Critically, SDG3 articulates the core elements of the right to health; the targets and indicators
provide an integral framework for assessing the needs in each country, monitoring the progress
of governments in the realization of the right to health, and identifying areas for developed
countries to “cooperate and assist”.
The CESCR actually identifies as part of a government's core obligations, the obligation
to create a strategy and plan of action for the realization of the right to health that includes
“methods, such as right to health indicators and benchmarks, by which progress can be closely
monitored.”80 The international community, with leadership from the CESCR and the Special
Rapporteur on the Right to Health, should focus attention on the annual progress across countries
on the indicators of SDG3, with a special focus on the poorest countries.
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In order for developed countries to be held accountable for their obligations under the
ICESCR, there needs to be a clear articulation of the extraterritorial obligations of States (as well
as clarity on the obligations of non-State actors, including multinational corporations and
international financial institutions).81 With an improved and emboldened mandate, the CESCR
can assume the responsibility and capacity to hold countries accountable for their obligations to
provide international assistance and cooperation, with assistance from the Special Rapporteur on
the right to health. The CESCR, for instance, makes Concluding Observations on the reports of
States Parties to the ICESCR, and has at times commented and made recommendations to
increase development assistance. Furthermore, civil society organizations submit “shadow
reports,” which the CESCR examines along with States Parties' reports, providing additional
commentary on the States' compliance with their obligations. The CESCR has often incorporated
information from these civil society reports in its recommendations.82 The mandate of the
CESCR includes not only collecting these reports and making specific recommendations, but
also assessing and benchmarking the compliance of developed countries with respect to their
international assistance obligations. Finally, the Special Rapporteurs also make evaluations and
recommendations to States Parties on the status of compliance with the obligation to cooperate
and assist with the realization of the right to health.

Outlines of a post-COVID-19 international financial programme to support health for all
Finance is merely an enabler, of course, to be combined with on-the-ground systems for
delivery, monitoring, and evaluation. Several such systems are being put in place, mainly as the
result of progress in scaling up programmes to fight AIDS, TB, malaria, COVID-19, and other
infectious diseases. The Global Fund to Fight AIDS, TB and Malaria, and the Global Alliance
for Vaccines and Immunization are the two main multilateral donor funds established early in the
millennium to finance the rollout of disease control efforts, and the results of these efforts have
been enormously positive. The challenge of COVID-19, of course, changes the scale of the
global commitment needed to achieve the targets of SDG3.
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In order to prepare to achieve SDG 3 in all countries, including the poorest, by the target
year 2030, we recommend five urgent priorities:
1. First, rich countries will need to scale up their overall aid to health. Our estimate is that

around 0.1 per cent of donor GDP each year, roughly $50 billion as of 2020, would be
needed to close the health financing gap for the low-income countries, assuming that
those countries follow through on their own domestic resource mobilization in national
budgets. This estimate does not include the extraordinary costs associated with the
COVID-19 pandemic, which are additional. The depression following COVID-19
creates enormous strains on health budgets and possibly an opportunity to build on the
urgent investment in testing, tracing, treatment and vaccines to maintain increased
investment in the health sector.
2. Second, donor countries and philanthropic foundations should properly and urgently fund

the various pooled-financing mechanisms established to help low-income countries to
cover the costs of responding to the COVID-19 pandemic,83 for example, to cover the
costs of implementing a newly developed vaccine under the Covax program.84
3. Third, donor countries should provide targeted funding for scaling up primary health systems in
order to achieve Universal Health Coverage (SDG 3.8). This can most readily be handled by
expanding the responsibilities of GAVI and the Global Fund to Fight AIDS, TB, and Malaria, so
that these two funds would help to cover the costs of physical infrastructure of the primary health
system, training of health workers, and deployment of remunerated health workers, including
Community Health Workers (CHWs).
4. Fourth, ministries of health should deploy national-scale information and

communications technologies (ICTs) in order to create low-cost, state-of-the-art health
delivery systems that can benefit from recent advances of ICTs. New possibilities,
spurred on by the urgent need to respond to the COVID-19 pandemic, include
empowering CHWs with smart-phone technologies, distance training of health workers in
online courses, distance diagnostics, telemedicine, remote monitoring of patients,
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emergency response systems, real-time dashboards for health informatics, medical
electronic records, and more.
5. Fifth, health systems in low-income countries should begin expanding universal health

coverage to include the prevention and treatment of non-communicable diseases (in line
with SDG 3, Target 3.4), including cardiovascular, respiratory, metabolic, mental health,
and cancers. Many of these non-communicable diseases now may be prevented or treated
with relatively low-cost interventions that have become available in the past decade or so.
Conclusion
As the former Special Rapporteur on the Right to Health, Paul Hunt, said over a decade
ago, “Confronted with such a complex and colossal challenge as global poverty, it is extremely
important that development practitioners use all the tools available in their workshop, including
the national and international human rights commitments of developing and developed states.”85
The international commitments exist in the human rights treaties, the SDGs, global conferences
on financing development and the policies and programs of international financial and
development institutions, but enforcement is weak and global cooperation and assistance – in
line with existing commitments and obligations – are absolutely necessary to solve the global
health crisis and to realize the right to health that has been affirmed by all nations for many
years. It is unacceptable that the “available resources” standard of the ICESCR has resulted in
substantially different standards of the right to health between developing and developed
countries. It is imperative that the global community cooperate to “close the gap between
developing and developed countries' highest attainable standards.”86
An economic perspective on realizing the right to health can be useful in this context,
complementing the existent international obligations by identifying the most cost-effective
investments for improving health systems, quantifying the financing gap to realize the right to
health in poor countries, and creating benchmarks for measuring success and monitoring
progress. Efforts must be scaled up. The means for success already exist. International human
rights commitments call on us to make the effort. The needs are urgent, and the 2015-2030
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timeframe for the SDGs offers a unique opportunity to achieve for global health what the MDGs
failed to achieve and what the pandemic renders all the more urgent.
[BOX] Emergency Financing for Fighting COVID-19
In its September 11, 2020, Resolution, the UN General Assembly called for “intensified
international cooperation and multilateral efforts in handling disease outbreaks, including by
sharing timely, accurate and transparent information, exchanging epidemiological and clinical
data, sharing materials necessary for research and development, and implementing the
International Health Regulations (IHR 2005)3 and relevant guidance.”87 The Resolution
emphasized the importance of international cooperation to “mitigate any drawback towards
achieving the Sustainable Development Goals” and highlighted the unique debt vulnerabilities of
low- and middle-income countries during the pandemic.88 The UN launched a multibillion dollar
coordinated global humanitarian Response Plan to fight COVID-19 in March, with additional
annexes and financial appeals being added in May and July.89 As of October 23, 2020, the
Response Plan was only 32.7 percent funded, with $10.3 billion earmarked to fight the pandemic
in low-income and particularly vulnerable countries.90 The Office for the Coordination of
Humanitarian Affairs has been assessing the use of Country-Based Pooled Funds (CBPFs) at the
field level, and as of October 23, 2020, sixteen CBPFs had provided $226 million to COVID-19
responses. OCHA is also coordinating with State governments to prepare response plans and
administer aid effectively.91 Dozens more in-country COVID-19 response programmes have
been supported through the $134 million released from the UN Central Emergency Response
Fund.92 The IMF has provided emergency financing and doubled access to both its Rapid Credit
Facility and Rapid Financing Instrument, allowing it to provide approximately $100 billion in
financing.93 By the end of September 2020, the IMF Executive Board had approved around $31
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billion in emergency funding for 76 countries and has extended flexible lines of credit to three. 94
Furthermore, the IMF has provided immediate deb service relief to 29 countries through its
Catastrophe Containment and Relief Trust.95 The G20 also suspended debt service on lines of
bilateral credit for low-income countries. As of the end of September 2020, around sixty percent
of eligible countries has already applied for this suspension.96 Most of the important
interventions to support the basic obligations of developing country governments are low-cost
interventions that nevertheless are not within reach of most developing countries.
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